COVID: FDA Authorizes Booster for Pfizer and Moderna Vaccines for All Adults

La FDA aprueba la dosis de refuerzo de Pfizer y Moderna contra el covid-19 para todos los adultos.

The FDA approves the booster dose of Pfizer and Moderna against COVID-19 for all adults.

Photo: Justin Sullivan / Getty Images

The Federal Food and Drug Administration (FDA) Authorized Boosters of Pfizer / BioNTech and Moderna Covid / 19 Vaccines for All Adults. Previously, they had given the green light to the booster dose in those over 65 and other high-risk people.

The ball now falls on the court of the Centers for Disease Control and Prevention, CDC, who will discuss the issue.

In states like California, New Mexico and Colorado, or cities like New York, there was already a green light for the adult booster dose.

Both of them last week applied to the FDA for authorization for the boosters, based on the results of a trial that involved more than 10,000 participants, and found that boosters were safe and 95% effective against symptomatic covid, compared to the two-dose program in which the delta variant was dominant.

According to recent studies, immunity from vaccines may begin to wane over time, immunity that is reinforced precisely by the booster doses.

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, previously told CNN that those over 60 who have received a booster in Israel showed less likely to become seriously ill than those without a booster dose.

CDC data indicates that approximately 16% of fully vaccinated people have received booster doses of one of the COVID-19 vaccines.

This also interests you:
– United States launches plan to increase vaccine production
– Michigan and Minnesota report an increase in covid patients with figures not seen in months
– The United States will announce the purchase of 10 million Pfizer treatments against covid-19


See also  The US has about 3,000 cases of monkeypox; authorities hope to stop the outbreak

Leave a Comment

Your email address will not be published.